Aralez Pharmaceuticals US – Committee Objects to Deerfield Bid Protections, Cites “Commercial Absurdity” of “Value Grabs”

October 3, 2018 – Aralez Pharmaceuticals’ Official Committee of Unsecured creditors filed an objection [Docket No. 140] to the Debtors’ bid procedures Motion [Docket No. 113]. The Committee asserts, “When the Debtors filed for Chapter 11 and CCAA relief, they explained the purpose and game-plan of their bankruptcies as follows: (i) these would be very…